Intelligene

Intelligene CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Intelligene (7832.TWO) as of Oct 21, 2026 is -96.44 %. In the previous year, CapEx to Operating Cash Flow Ratio was -100.43 % — a change of -3.98% (higher).

CapEx/OCF

-96.44 %

YoY

-3.98%

Last updated:

CapEx to Operating Cash Flow Ratio of Intelligene is 2024 -96.44 % . CapEx to Operating Cash Flow Ratio of Intelligene was 2023 -100.43 % . It decreases by -3.98% higher compared to the previous year.

The Intelligene CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2023
-100.43 TWD
Jan 1, 2024
-96.44 TWD
The Intelligene CapEx/OCF history
YEARCapEx/OCFYoY
-96.44 %-3.98%
-100.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligene Stock analysis

What does Intelligene do? Intelligene Inc develops innovative RNA gene therapy drugs using siRNA gene compilation technology for treating pneumonia and influenza. The company focuses on research and development of nucleic acid drugs targeting all cases of pneumonia and influenza. Intelligene Inc is a Taiwan-based company with 20 full-time employees operating in the pharmaceutical industry. The company's primary revenue comes from the development and potential commercialization of its RNA-based gene therapy drugs. Intelligene Inc is engaged in the research and development of innovative nucleic acid drugs based on siRNA technology for pneumonia and influenza treatments. The firm aims to provide novel therapeutic solutions for respiratory diseases through its proprietary technology. Intelligene Inc's products target medical professionals and healthcare institutions seeking advanced treatments for pneumonia and influenza. The company's research focuses on developing drugs that address all cases of these respiratory conditions. The firm operates within the pharmaceutical sector with a specific emphasis on RNA-based therapies for respiratory illnesses. Intelligene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intelligene stock

CapEx to Operating Cash Flow Ratio of Intelligene is -96.44 % in 2024.

CapEx to Operating Cash Flow Ratio of Intelligene changed from -100.43 % to -96.44 %, representing a -3.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Intelligene since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Intelligene with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Intelligene

All Key Metrics — Intelligene